Diabetes mellitus type 1
Diabetes mellitus type 1 Microchapters |
Differentiating Diabetes mellitus type 1 from other Diseases |
Diagnosis |
Treatment |
Cardiovascular Disease and Risk Management |
Case Studies |
Diabetes mellitus Main page |
Patient Information |
---|
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]
Overview
Historical Perspective
Pathophysiology
Risk Factors
Screening
Epidemiology and demographics
Natural history, Complications, and Prognosis
Classification
Causes
Differentiating Type page name here from other Disorders
Diagnosis
History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical: Medical Therapy
Surgical: Surgery
Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies|Social issues
See also
References
Data from the Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
External links
- American Diabetes Association
- Diabetes
- Diabetes Australia-NSW
- Canadian Diabetes Association
- Diet, Nutrition and the prevention of chronic diseases (including diabetes) by a Joint WHO/FAO Expert consultation (2003)
- Centers for Disease Control Diabetes Section
- Diabetes UK
- Diabetes Health Institute
- Diabetes Institute for Immunology and Transplantion
- The Immunology of Diabetes Society
- International Diabetes Federation
- Juvenile Diabetes Research Foundation
- MedlinePlus Diabetes from the U.S. National Library of Medicine
- National Diabetes Education Program
- National Diabetes Information Clearinghouse
- Primary Care Diabetes Europe
- World Health Organization fact sheet on diabetes
- World Health Organization—The Diabetes Programme
- Diabetic Medical ID Tag
References
Overview
Entities involved in research
This section is a complete list of mainly commercial companies but also other entities, namely governmental institutions and individual persons, actively involved in research towards finding a cure to diabetes type 1.
It does not list research funds, hospitals in which research is undertaken, etc., but only the industrious, actual developers of such products.
Entities are listed along with their status of research in that field, so that also entities which ceased research into finding a cure to diabetes type 1 may be listed.
Entities are alphabetically listed.
- Cerco Medical [4] – Present status: Unknown
- Denise Faustman [5] – Present status: Working on immune modification
- DeveloGen [6] – Present status: Developing DiaPep 277
- Diamyd Medical [7] – Present status: Developing GAD65-based vaccine (phase III application submitted to the FDA)
- Encelle [8] – Present status: On hold; awaiting decision on whether to move forward into encapsulated beta cell transplantation.
Further reading
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Diabetes in America Textbook (PDFs)